Table 1. Subgroup analyses for the correlation between SUV and ADC.

factorssubgroupnr (95% CI)p value
study designprospective22-0.34 (-0.39, -0.28)>0.05
retrospective21-0.33 (-0.37, -0.29)
scanning modalityPET/CT+MRI32-0.32 (-0.37, -0.28)>0.05
PET/MRI11-0.33 (-0.37, -0.29)
cancer typelung cancer11-0.42 (-0.48, -0.35)
head-neck cancer6-0.29 (-0.41, -0.17)
cervical cancer4-0.08 (-0.26, -0.10)
breast cancer4-0.23 (-0.33, -0.13)